Zacort 30 Tablet

About Zacort 30 Tablet

The tablet Zacort 30 contains Deflazacort and is made by One Pharma Ltd. Only your doctor can confirm whether Zacort 30 is suitable for your condition and what it is being used to treat in your case.

There are 28 brands of Deflazacort listed in Bangladesh. The lowest listed price is Dezert 6 mg Tablet at ৳ 8.00 per unit.

What is Zacort 30 Tablet?

Made by One Pharma Ltd., Zacort 30 is a tablet whose active ingredient is Deflazacort. Because it affects several body systems, Zacort 30 is used only under medical supervision, and the doctor decides the strength and course that suit each person. Ask your doctor or pharmacist if you are unsure whether it suits you.

Uses of Zacort 30

Only your doctor can confirm whether Zacort 30 is suitable for your condition and what it is being used to treat in your case. It is also used for rheumatoid arthritis, juvenile chronic arthritis, and polymyalgia rheumatica. Deflazacort is used in a range of conditions linked to inflammation and immune activity. Your doctor will decide if this medicine is suitable for you.

How to use Zacort 30

Swallow the tablet as directed, and do not stop it on your own, because steroid medicines may need to be tapered. Zacort 30 is taken by mouth. Swallow the tablet with water. Take Zacort 30 exactly as the doctor prescribes. If you miss a dose, ask your doctor or pharmacist what to do. The doctor decides the dose and how long the course lasts; do not change it yourself.

Side effects of Zacort 30

It can also increase the risk of infection, slow healing, and cause skin thinning, stretch marks, acne, or blood vessel changes. Some people may notice skin changes such as thinning or stretch marks. It can also affect hormone levels, vision, and fluid balance. Tell your doctor if you notice any effect that worries you. Contact your doctor if you have severe stomach pain, signs of infection, vision changes, or unusual swelling.

Safety and precautions

In pregnancy, it may carry risks for the baby, so it is used only if the benefits outweigh the risks. Do not receive live virus vaccines while taking it. Zacort 30 needs care in people with heart disease or heart failure, high blood pressure, blood clotting problems, stomach or bowel ulcers, diabetes, or a history of these conditions, and the doctor may want regular monitoring. The doctor will decide if it is suitable for you.

Frequently asked questions

What is Zacort 30 used for?

Only your doctor can confirm whether Zacort 30 is suitable for your condition and what it is being used to treat in your case. It is also used for rheumatoid arthritis, juvenile chronic arthritis, and polymyalgia rheumatica.

How is Zacort 30 used?

Swallow the tablet as directed, and do not stop it on your own, because steroid medicines may need to be tapered. Zacort 30 is taken by mouth.

What should I watch for while using Zacort 30?

It can also increase the risk of infection, slow healing, and cause skin thinning, stretch marks, acne, or blood vessel changes. Some people may notice skin changes such as thinning or stretch marks.

Who should be careful with Zacort 30?

In pregnancy, it may carry risks for the baby, so it is used only if the benefits outweigh the risks. Do not receive live virus vaccines while taking it.

Indications

Deflazacort is indicated in-
  • Anaphylaxis, asthma, severe hypersensitivity reactions
  • Rheumatoid arthritis, juvenile chronic arthritis, polymyalgia rheumatica
  • Systemic lupus erythematosus, dermatomyositis, mixed connective tissue disease (other than systemic sclerosis), polyartritis nodosa, sarcoidosis
  • ... Read more
Deflazacort is indicated in-
  • Anaphylaxis, asthma, severe hypersensitivity reactions
  • Rheumatoid arthritis, juvenile chronic arthritis, polymyalgia rheumatica
  • Systemic lupus erythematosus, dermatomyositis, mixed connective tissue disease (other than systemic sclerosis), polyartritis nodosa, sarcoidosis
  • Pemphigus,bullous pemphigoid, pyoderma gangrenosum
  • Minimal change nephrotic syndrome, acute interstitial nephritis
  • Rheumatic carditis
  • Ulcerative colitis, Crohn's disease
  • Uveitis, optic neuritis
  • Autoimmune haemolytic anaemia, idiopathic thrombocytopenic purpura
  • Acute and lymphatic leukaemia, malignant lymphoma, multiple myeloma
  • Immune suppression in transplantation

Pharmacology

Deflazacort provides anti-inflammatory action by inhibiting Phospholipase A2 enzyme which is responsible for prostaglandin synthesis. Besides Deflazacort decreases the release of certain chemicals that are important in the immune system. By decreasing the release of these chemicals Deflazacort provides immunosuppressive action.

Dosage & Administration

Adults-
  • For acute disorders: Up to 120 mg/day Deflazacort may need to be given initially. Maintenance doses in most conditions are within the range of 3-18 mg/day.
  • Rheumatoid arthritis: The maintenance dose is usually within the range of 3-18 mg/day. The smallest effective dose should be used and increased if necessary.
  • Bronchial asthma: In the treatment of an acute attack, high doses of 48-72 mg/day may be needed depending on severity and gradually reduced once the attack has been controlled. For maintenance in chronic asthma, doses should be titrated to the lowest dose that controls symptoms.
  • Other conditions: The dose of Deflazacort depends on clinical need titrated to the lowest effective dose for maintenance. Starting doses may be estimated on the basis of ratio of 5 mg prednisone or prednisolone to 6 mg.
Children: There has been limited exposure of children to Deflazacort in clinical trials. In children, the indications for glucocorticoids arethe same as for adults, but it is important that the lowest effective dosage is used. Alternate day administration may be appropriate. Doses of Deflazacort usually lie in the range 0.25-1.5 mg/kg/day.

The following ranges provide general guidance:
  • Juvenile chronic arthritis: The usual maintenance dose is between 0.25-1.0 mg/kg/day.
  • Nephrotic syndrome: Initial dose of usually 1.5 mg/kg/day followed by down titration according to clinical need.
  • Bronchial asthma: On the basis of the potency ratio, the initial dose should be between 0.25-1.0 mg/kg on alternate days.
Deflazacort withdrawal: In patients who have received more than physiological doses of systemic corticosteroids (approximately 9 mg per day or equivalent) for greater than 3 weeks, withdrawal should not be abrupt. How dose reduction should be carried out depends largely on whether the disease is likely to relapse as the dose of systemic corticosteroids is reduced.

Interaction

Deflazacort is metabolized in the liver. It is recommended to increase the maintenance dose of Deflazacort if drugs which are liver enzyme inducers are co-administered, e.g. rifampicin, rifabutin, carbamazepine, phenobarbitone, phenytoin, primidone and aminoglutethimide. For drugs which inhibit liver enzymes, (e.g. ketoconazole) it may be possible to reduce the maintenance dose of Deflazacort.

Contraindications

Hypersensitivity to or any of the ingredients. Patients receiving live virus immunization.

Side Effects

GI disturbances, musculoskeletal, endocrine, neuropsychiatric, ophthalmic, fluid and electrolyte disturbances; susceptible to infection, impaired healing, hypersensitivity, skin atrophy, striae, telangiectasia, acne, myocardial rupture following recent Ml, thromboembolism.

Pregnancy & Lactation

Pregnancy: Deflazacort does cross the placenta. However, when administered for prolonged periods or repeatedly during pregnancy, corticosteroids may increase the risk of intrauterine growth retardation. As with all drugs, corticosteroids should only be prescribed when the benefits to the mother and child outweigh the risks.

Nursing Mother: Corticosteroids are excreted in breast milk, although no data are available for Deflazacort. Doses of up to 50 mg daily of Deflazacort are unlikely to cause systemic effects in the infant. Infants of mothers taking higher doses than this may have a degree of adrenal suppression but the benefits of breastfeeding are likely to outweigh any theoretical risk.

Precautions & Warnings

The following clinical conditions require special caution and frequent patient monitoring is necessary-
  • Cardiac disease or congestive heart failure (except in the presence of active rheumatic carditis), hypertension, thromboembolic disorders. Glucocorticoids can cause salt and water retention and increased excretion of potassium. Dietary salt restriction and potassium supplementation may be necessary.
  • Gastritis or oesophagitis, diverticulitis, ulcerative colitis if there is the probability of impending perforation, abscess or pyogenic infections, fresh intestinal anastomosis, active or latent peptic ulcer.
  • Diabetes mellitus or family history, osteoporosis, myasthenia gravis, renal insufficiency.
  • Emotional instability or psychotic tendency, epilepsy.
  • Previous corticosteroid-induced myopathy.
  • Liver failure.
  • Hypothyroidism and cirrhosis, which may increase the glucocorticoid effect.
  • Ocular herpes simplex because of possible corneal perforation.

Storage Conditions

Store in a cool (below 25°C) and dry place, protected from light & moisture. Keep out of the reach of children.

Alternative brands of Deflazacort

Other brands with the same generic name, cheapest first.

See all 28 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.